AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $633,000 | +155.2% | 10,579 | +19.9% | 0.00% | – |
| Q3 2019 | $248,000 | -23.7% | 8,822 | +2.9% | 0.00% | – |
| Q2 2019 | $325,000 | +21.7% | 8,572 | +25.5% | 0.00% | – |
| Q1 2019 | $267,000 | +89.4% | 6,828 | +3.0% | 0.00% | – |
| Q4 2018 | $141,000 | -27.7% | 6,632 | +34.5% | 0.00% | – |
| Q3 2018 | $195,000 | +3.7% | 4,932 | 0.0% | 0.00% | – |
| Q2 2018 | $188,000 | +67.9% | 4,932 | +33.0% | 0.00% | – |
| Q1 2018 | $112,000 | -12.5% | 3,709 | -9.4% | 0.00% | – |
| Q4 2017 | $128,000 | -4.5% | 4,096 | -13.0% | 0.00% | – |
| Q3 2017 | $134,000 | +65.4% | 4,708 | +11.2% | 0.00% | – |
| Q2 2017 | $81,000 | +350.0% | 4,232 | +290.4% | 0.00% | – |
| Q1 2017 | $18,000 | -10.0% | 1,084 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | – | 1,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
| Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
| Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
| Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
| Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
| Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
| Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
| Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |